Showing 5841-5850 of 7669 results for "".
Exosome Therapy: Explained
https://practicaldermatology.com/conferences/scale-2023/exosome-therapy-explained/20200/Jane Yoo, MD, explains exactly what exosomes are and highlights some current therapeutic uses for exosome therapy including treating hair loss and reducing redness after laser skin resurfacing.Is a Good Faith Estimate Required for a Filler or Neuromodulator Treatment?
https://practicaldermatology.com/topics/practice-management/is-a-good-faith-estimate-required-for-a-filler-or-neuromodulator-treatment/23852/The latest updates from CMS do not specifically mention aesthetics in reference to good faith estimates, but there are indications that some aesthetic and dermatology services will require them. What about an appointment for injectables?An Inside Look at How Incyte is Addressing Unmet Needs of Patients with Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/an-inside-look-at-how-incyte-is-addressing-unmet-needs-of-patients-with-atopic-dermatitis/20156/Ahmad Naim, Vice President of US Medical Affairs at Incyte, discusses the challenges around atopic dermatitis (AD) management and how Incyte is utilizing its expertise in immunology to address unmet needs for patients.Targeting Cellulite: Evolving Approaches
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/targeting-cellulite-evolving-approaches/23796/New treatments mean that dermatologists can improve treatment outcomes for the 90% of women who have cellulite.What to do if your practice’s social accounts are inactive
https://practicaldermatology.com/topics/practice-management/what-to-do-if-your-practices-social-accounts-are-inactive/20127/Social media is the can’t miss marketing platform of 2022. However, it has been around long enough that many businesses have already tried it and given up years ago. If you are among the many dermatology practices with an old, outdated, nearly inactive Facebook or other social accounts, check out thEyeing a Treatment for Syringoma
https://practicaldermatology.com/series/scientifically-speaking/eyeing-a-treatment-for-syringoma/20112/Listen as Joel L. Cohen, MD describes early evidence for the use of nano pulse stimulation to treat syringoma, a notoriously challenging target.DermWireTV: Dupixent for Kids; Epsolay Launch; Scleroderma Awareness; Chicago Derms Celebrate Diversity
https://practicaldermatology.com/topics/practice-management/dermwiretv-dupixent-for-kids-epsolay-launch-scleroderma-awareness-chicago-derms-celebrate-diversity/20100/Epsolay (benzoyl peroxide 5%) Cream from Galderma is now available for the topical treatment of rosacea. It was developed by Sol-Gel. Dupixent from Sanofi and Regeneron is now the only biologic medicine FDA approved for use from infancy through adulthood for the management of atopic dermatitis. JuneThe Right Spin on PRP: How to Achieve Success
https://practicaldermatology.com/conferences/aad-2022/the-right-spin-on-prp-how-to-acheive-success/20078/While the use of PRP in dermatology seems fairly straightforward, numerous factors can influence outcomes. Terrence Keaney, MD discusses some key considerations to optimize outcomes with the use of this evolving treatment intervention in a busy dermatology practice.Finally: JAK Inhibitors Are Here
https://practicaldermatology.com/topics/psoriasis/finally-jak-inhibitors-are-here/20076/JAK inhibitors reach across all of dermatology, says Brett King, MD, PhD, who says the existing data is impressive and even more data are forthcoming for this class of medicine that will "change the landscape of dermatology."Tried-and-True to Edge-of-Evidence Options: AD Treatment Guidelines
https://practicaldermatology.com/conferences/aad-2022/tried-and-true-to-edge-of-evidence-options-ad-treatment-guidelines/20071/Peter A. Lio, MD discusses updates to the atopic dermatitis treatment guidelines. From biologics to JAK inhibitors to an exciting pipeline, there are so many options to target AD. Dr. Lio also discusses the potential benefits of using gentler adjunctive therapies like botanicals and naturals as part